Labcyte wins $1M award for protein biomarker research; Investigators outline Roche drug's impact on macular degeneration;

> The NCI has awarded Labcyte $1 million to work on new technology for evaluating protein biomarkers for cancer, beginning with a focus on breast cancer. Story (reg. req.)

> Investigators have been spelling out the effect of Roche's ($RHHBY) lampalizumab on a biomarker-defined subset of patients with macular degeneration. Report (reg. req.)

Suggested Articles

LabCorp, Philips and Mount Sinai are coming together to develop an AI-driven pathology center of excellence, aimed initially at cancer diagnosis.

The FDA followed through with plans to end its Alternative Summary Reporting program, making 20 years’ worth of device safety data publicly available.

Janssen tapped Resolution Bioscience to develop a companion diagnostic for Zejula in patients with metastatic castration-resistant prostate cancer.